Arena Pharmaceuticals, Inc. Deferred Revenue
Arena Pharmaceuticals, Inc. had Deferred Revenue of $800.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-02-28
- 2018-09-30: Deferred Revenue, Current $800.00K.
- 2018-06-30: Deferred Revenue, Current $800.00K.
- 2018-03-31: Deferred Revenue, Current $800.00K.
- 2017-12-31: Deferred Revenue, Current $1.11M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2018-09-30 | $800.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $800.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $800.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $1.11M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $27.99M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $30.98M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $33.17M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $4.41M 10-K · filed 2018-03-14 | $35.29M 10-K · filed 2017-03-15 |
| 2016-09-30 | $22.52M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $20.02M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $22.24M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $21.43M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $23.21M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $26.92M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $26.29M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $15.24M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $19.87M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $32.46M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $35.39M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $37.86M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $29.16M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $7.80M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $15.45M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $15.45M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $3.50M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $3.85M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $3.51M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $3.47M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $3.85M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $3.87M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $3.85M 10-K · filed 2012-03-15 |